Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature

Patients with advanced pancreatic adenocarcinoma have a poor prognosis, and to date, no treatment method has had a significant impact on the disease. In general, the mean overall survival time of such patients receiving conventional chemotherapy and radiotherapy is <6 months. In the present case...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, WEI, XU, LIN PING, DI ZHAO, LING, WANG, LI, ZHANG, YONG, GAO, QUAN LI, MAI, LING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629180/
https://www.ncbi.nlm.nih.gov/pubmed/23599807
http://dx.doi.org/10.3892/ol.2013.1200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629180/
https://www.ncbi.nlm.nih.gov/pubmed/23599807
http://dx.doi.org/10.3892/ol.2013.1200

Ejemplares similares